Video

“You can really change the life of a patient quickly,” Anat Loewenstein Discusses ARVO, Ophthalmology

Author(s):

"I’ve been going to ARVO for 20 years...every year I learn a lot,” Loewenstein says.

In the third and final installment of MD Magazine’s ranging interview with Anat Loewenstein, the Chair of the Department of Ophthalmology at the Tel Aviv Medical Center, at ARVO 2017, the distinguished ophthalmologist discussed her love of the specialty and the importance of meetings like ARVO.

“The debates that come around the posters, and the relatively long talks in the meeting, and a lot of discussion bring along a lot of interaction and interesting ideas that are very important. I’ve been going to ARVO for 20 years, every year, and every year that I come I learn a lot and enjoy a lot,” Loewenstein told us.

Related Videos
Achieving Complete Renal Response and Reducing Corticosteroid Use in Lupus Nephritis Treatment With Obinutuzmab, with Richard Furie, MD
Aflibercept 8 mg Shows Durability at 3 Years in Wet AMD with W. Lloyd Clark, MD | Image Credit: Palmetto Retinal Center
Aflibercept 8 mg Noninferior for RVO in QUASAR with W. Lloyd Clark, MD | Image Credit: Palmetto Retinal Center
Understanding Angioedema in Urticaria, with Jonathan Bernstein, MD
Identifying B-cell Depleting Agents for Lupus Nephritis, with Richard Furie, MD
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
© 2025 MJH Life Sciences

All rights reserved.